Skip to content

Omnicell OMCL Stock-Based Comp

Stock-Based Comp at other companies

Baxter International logo
Baxter InternationalBAX
$10M0.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58M+41.5%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$3.68M-76.6%
Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
$1.86M-53.1%
Cardinal Health logo
Cardinal HealthCAH
$129M+316%
Cencora logo
CencoraCOR
$28M-1.6%

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's stock-based comp?
Omnicell (OMCL) reported stock-based comp of $9.5M in Q1 2026.
How has Omnicell's stock-based comp changed year-over-year?
Omnicell's stock-based comp decreased by 11.9% year-over-year, from $10.79M to $9.5M.
What is the long-term trend for Omnicell's stock-based comp?
Over 4 years (2021 to 2025), Omnicell's stock-based comp has grown at a -4.3% compound annual growth rate (CAGR), from $53.16M to $44.5M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.